A novel metabolic balance model for describing the metabolic disruption of and interactions between cardiovascular-related markers during acute myocardial infarction

Metabolism: Clinical and Experimental

Volumn 62, Issue 10, 2013, Pages 1357-1366

  He, Hua ^a   Wang, Shijun ^a   Li, Xi ^a   Wang, Haidong ^a   Zhang, Wenting ^a   Yuan, Linhua ^a   Liu, Xiaoquan ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Cardiovascular disease; Metabolic module; Multimarker; Rat

Indexed keywords

ADENOSINE TRIPHOSPHATE; DIMETHYLARGININASE; N(G),N(G) DIMETHYLARGININE; AMIDASE; ARGININE; BIOLOGICAL MARKER; N,N-DIMETHYLARGININE;

ACUTE HEART INFARCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVITY; KIDNEY FUNCTION; MALE; METABOLIC BALANCE; METABOLIC DISORDER; NONHUMAN; PRIORITY JOURNAL; RAT; ACUTE DISEASE; ANALOGS AND DERIVATIVES; ANIMAL; BLOOD; CARDIOVASCULAR SYSTEM; HEART INFARCTION; KIDNEY; META ANALYSIS; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ACUTE DISEASE; ADENOSINE TRIPHOSPHATE; AMIDOHYDROLASES; ANIMALS; ARGININE; BIOLOGICAL MARKERS; CARDIOVASCULAR SYSTEM; KIDNEY; MALE; MYOCARDIAL INFARCTION; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84884533609     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2013.04.011     Document Type: Article

References (47)

1. N.M. Gruning, H. Lehrach, and M. Ralser Regulatory crosstalk of the metabolic network Trends Biochem Sci 35 4 2010 220 227
2. W. Rosamond, K. Flegal, and K. Furie Heart disease and stroke statistics - 2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Circulation 117 4 2008 e25 e146
3. J.P. Castro, F.A. El-Atat, and S.I. McFarlane Cardiometabolic syndrome: pathophysiology and treatment Curr Hypertens Rep 5 5 2003 393 401
4. V. Cavalca, F. Veglia, and I. Squellerio Circulating levels of dimethylarginines, chronic kidney disease and long-term clinical outcome in non-ST-elevation myocardial infarction PLoS One 7 11 2012 e48499
5. B.V. Djordjevic, R. Pavlovic, and V. Cosic High clinical accuracy of asymmetric dimethylarginine and symmetric dimethylarginine in patients with ischemic heart disease Amino Acids 43 6 2012 2293 2300
6. T.M. Lu, M.Y. Chung, and M.W. Lin Plasma asymmetric dimethylarginine predicts death and major adverse cardiovascular events in individuals referred for coronary angiography Int J Cardiol 153 2 2011 135 140
7. N. Sen, M.F. Ozlu, and E.O. Akgul Elevated plasma asymmetric dimethylarginine level in acute myocardial infarction patients as a predictor of poor prognosis and angiographic impaired reperfusion Atherosclerosis 219 1 2011 304 310
8. A. Yilmaz, S. Bekpinar, and Y. Unlucerci High concentrations of asymmetric dimethylarginine are associated with ST-segment resolution failure after reperfusion for acute myocardial infarction Clin Chem Lab Med 49 5 2011 903 907
9. T. Teerlink Adma metabolism and clearance Vasc Med 10 Suppl 1 2005 S73 S81
10. M. Visser, W.J. Paulus, and M.A. Vermeulen The role of asymmetric dimethylarginine and arginine in the failing heart and its vasculature Eur J Heart Fail 12 12 2010 1274 1281
11. M.C. Stuhlinger, P.S. Tsao, and J.H. Her Homocysteine impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine Circulation 104 21 2001 2569 2575
12. J. Beltowski, and A. Kedra Asymmetric dimethylarginine (ADMA) as a target for pharmacotherapy Pharmacol Rep 58 2 2006 159 178
13. T. Gibson Hyperuricemia, gout and the kidney Curr Opin Rheumatol 24 2 2012 127 131
14. M.P.C. Siroen, T. Teerlink, and R.J. Nijveldt The clinical significance of asymmetric dimethylarginine Annu Rev Nutr 26 2006 203 228
15. N. Chen, Y.P. Leng, and W.J. Xu Contribution of endogenous inhibitor of nitric oxide synthase to hepatic mitochondrial dysfunction in streptozotocin-induced diabetic rats Cell Physiol Biochem 27 3-4 2011 341 352
16. W.C. Stanley, F.A. Recchia, and G.D. Lopaschuk Myocardial substrate metabolism in the normal and failing heart Physiol Rev 85 3 2005 1093 1129
17. J.S. Ingwall Energy metabolism in heart failure and remodelling Cardiovasc Res 81 3 2009 412 419
18. M.A. Lanaspa, L.G. Sanchez-Lozada, Y.J. Choi, M.A. Lanaspa, L.G. Sanchez-Lozada, and Y.J. Choi Uric acid induces hepatic steatosis by generation of mitochondrial oxidative stress: potential role in fructose-dependent and-independent fatty liver J Biol Chem 287 48 2012 40732 40744
19. G. Ndrepepa, S. Braun, and L. King Association of uric acid with mortality in patients with stable coronary artery disease Metabolism 61 12 2012 1780 1786
20. S. Kuwahata, S. Hamasaki, and S. Ishida Effect of uric acid on coronary microvascular endothelial function in women: association with EGFR and ADMA J Atheroscler Thromb 17 3 2010 259 269
21. S.K. Uehara, and G. Rosa Association of homocysteinemia with high concentrations of serum insulin and uric acid in brazilian subjects with metabolic syndrome genotyped for c677t polymorphism in the methylenetetrahydrofolate reductase gene Nutr Res 28 11 2008 760 766
22. J. Ellis, U.B. Wennerholm, and A. Bengtsson Levels of dimethylarginines and cytokines in mild and severe preeclampsia Acta Obstet Gynecol Scand 80 7 2001 602 608
23. A.H. Wu Early detection of acute coronary syndromes and risk stratification by multimarker analysis Biomark Med 1 1 2007 45 57
24. I. Ikonomidis, C.A. Michalakeas, and J. Lekakis Multimarker approach in cardiovascular risk prediction Dis Markers 26 5-6 2009 273 285
25. Y.C. Chen, W.W. Cao, and Y. Cao Using neural networks to determine the contribution of danshensu to its multiple cardiovascular activities in acute myocardial infarction rats J Ethnopharmacol 138 1 2011 126 134
26. E. Schwedhelm, R. Maas, and J. Tan-Andresen High-throughput liquid chromatographic-tandem mass spectrometric determination of arginine and dimethylated arginine derivatives in human and mouse plasma J Chromatogr B Analyt Technol Biomed Life Sci 851 1-2 2007 211 219
27. Y. Cao, J.G. Chai, and Y.C. Chen Beneficial effects of danshensu, an active component of salvia miltiorrhiza, on homocysteine metabolism via the trans-sulphuration pathway in rats Br J Pharmacol 157 3 2009 482 490
28. M.G. Volonte, G. Yuln, and P. Quiroga Development of an hplc method for determination of metabolic compounds in myocardial tissue J Pharm Biomed Anal 35 3 2004 647 653
29. Y.L. Tain, and C. Baylis Determination of dimethylarginine dimethylaminohydrolase activity in the kidney Kidney Int 72 7 2007 886 889
30. V. Vacic, L.M. Iakoucheva, and S. Lonardi Graphlet kernels for prediction of functional residues in protein structures J Comput Biol 17 1 2010 55 72
31. R.D. Peacock, P.A. Reneke, and W.D. Davis Quantifying fire model evaluation using functional analysis Fire Safety Journal 33 3 1999 167 184
32. S. Icer, A. Coskun, and T. Ikizceli Quantitative grading using grey relational analysis on ultrasonographic images of a fatty liver J Med Syst 36 4 2012 2521 2528
33. W. Li, Q.C. He, and X.M. Fan Evaluation of driver fatigue on two channels of EEG data Neurosci Lett 506 2 2012 235 239
34. H.Y. Lai, Y.Y. Chen, and S.H. Lin Automatic spike sorting for extracellular electrophysiological recording using unsupervised single linkage clustering based on grey relational analysis J Neural Eng 8 3 2011 036003
35. M.K. Yeung, J. Tegner, and J.J. Collins Reverse engineering gene networks using singular value decomposition and robust regression Proc Natl Acad Sci USA 99 9 2002 6163 6168
36. B. Mukherjee, Y.A. Ko, and T. Vanderweele Principal interactions analysis for repeated measures data: application to gene-gene and gene-environment interactions Stat Med 31 22 2012 2531 2551
37. J. Strobel, M. Mieth, and B. Endress Interaction of the cardiovascular risk marker asymmetric dimethylarginine (ADMA) with the human cationic amino acid transporter 1 (CAT1) J Mol Cell Cardiol 53 3 2012 392 400
38. M. Davids, M.C. Richir, and M. Visser Role of dimethylarginine dimethylaminohydrolase activity in regulation of tissue and plasma concentrations of asymmetric dimethylarginine in an animal model of prolonged critical illness Metabolism 61 4 2012 482 490
39. D. Garcia-Dorado, and J. Oliveras Myocardial oedema: a preventable cause of reperfusion injury? Cardiovasc Res 27 9 1993 1555 1563
40. M.T. Kuipers, H. Aslami, and A.P. Vlaar Pre-treatment with allopurinol or uricase attenuates barrier dysfunction but not inflammation during murine ventilator-induced lung injury PLoS One 7 11 2012 e50559
41. B.T. Emmerson The management of gout N Engl J Med 334 7 1996 445 451
42. F. Reverter, E. Vegas, and P. Sanchez Mining gene expression profiles: an integrated implementation of kernel principal component analysis and singular value decomposition Genomics Proteomics Bioinformatics 8 3 2010 200 210
43. E. Marinello, M. Pizzichini, and R. Guerranti Purine nucleotide catabolism in rat liver: labelling of uric acid and allantoin after treatment with oxonic acid and allopurinol Life Sci 68 10 2001 1131 1142
44. R.J. Nijveldt, T. Teerlink, and M.P. Siroen The liver is an important organ in the metabolism of asymmetrical dimethylarginine (ADMA) Clin Nutr 22 1 2003 17 22
45. S. Bhargava, A. Ali, and E.K. Bhargava Lowering homocysteine and modifying nutritional status with folic acid and vitamin B(12) in Indian patients of vascular disease J Clin Biochem Nutr 50 3 2012 222 226
46. A. Valjevac, A. Dzubur, and E. Nakas-Icindic Changes in serum homocysteine level follow two different trends in patients during early post myocardial infarction period Bosn J Basic Med Sci 9 2 2009 161 165
47. V. Trkulja, and S. Car On-admission serum uric acid predicts outcomes after acute myocardial infarction: systematic review and meta-analysis of prognostic studies Croat Med J 53 2 2012 162 172